Skip to content

Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia

Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia (Christ-Siemens-Touraine Syndrome)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01135888
Enrollment
28
Registered
2010-06-03
Start date
2009-04-30
Completion date
2010-02-28
Last updated
2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced Rise of Body Temperature, X-Linked Hypohidrotic Ectodermal Dysplasia

Keywords

hypohidrotic ectodermal dysplasia, exertional hyperthermia, cooling device

Brief summary

Because of their lack of sweat glands individuals with hypohidrotic ectodermal dysplasia (HED) are at particular risk of life-threatening hyperthermia during exercise in a warm environment. In this study, the effects of physical exercise are investigated in boys and male adolescents with X-chromosomally inherited HED as well as age-matched controls, who undergo standardized exertion on a bicycle ergometer at ambient temperatures of 25°C and 30°C. Body core temperature during and after ergometry, heart rate, performance, and serum lactate as a marker of metabolic stress are measured. Subjects with HED are expected to show an endangering rise of body temperature in connection with physical exercise. To clarify, whether novel cooling devices may reduce the likelihood of overheating, the effects of such devices are evaluated at 30°C.

Interventions

DEVICESkin cooling devices

Cooling vest and cooling bandana

Sponsors

Pervormance GmbH
CollaboratorUNKNOWN
University Hospital Erlangen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
7 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* for patients: hypohidrotic ectodermal dysplasia caused by EDA gene mutations * regular fluid intake prior to the investigation * written informed consent

Exclusion criteria

* acute febrile illness * acute or chronic heart disease * arterial hypertension * gastrointestinal disorders * implantable electronic devices * MRI investigation scheduled for the 5 days subsequent to the study * clinical signs or diagnostic findings of dehydration

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026